Document is current
Any future updates will be listed below
-
Authors
Li, Qian
Lesseur, Corina
Neugut, Alfred I.
Santella, Regina M.
Parada, Humberto Jr.
Teitelbaum, Susan
Chen, Jia https://orcid.org/0000-0001-6597-8577
-
Funding
Funding for this research was provided by:
National Institutes of Health (RO1 CA172460, UO1 ES019451, UO1CA/ES66572)
National Cancer Institute (K01 CA234317)
University of California, San Diego (U54 CA132384, U54 CA132379, P30 AG059299)
- License Information
-
More Information
Article History
Received: 13 January 2022
Accepted: 16 May 2022
First Online: 3 June 2022
Declarations
:
: Neugut has consulted for Otsuka, GlaxoSmithKline, Eisai, Hospira, and United Biosource Corp. He is a member of the Medical Advisory Board of EHE Intl. All other authors declare that they have no conflict of interest.
: Institutional Review Board approval was obtained from all participating institutions. All procedures were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
